{"frames":[{"target":{"name":"Frequency","spans":[{"start":0,"end":1,"text":"Annual"}]},"annotationSets":[{"rank":0,"score":32.44726627751411,"frameElements":[{"name":"Event","spans":[{"start":1,"end":2,"text":"review"}]},{"name":"Interval","spans":[{"start":0,"end":1,"text":"Annual"}]}]}]},{"target":{"name":"Medical_specialties","spans":[{"start":3,"end":4,"text":"medicine"}]},"annotationSets":[{"rank":0,"score":5.190858220391284,"frameElements":[{"name":"Specialty","spans":[{"start":3,"end":4,"text":"medicine"}]}]}]}],"tokens":["Annual","review","of","medicine",",","vol","66","."]}
{"frames":[{"target":{"name":"Medical_conditions","spans":[{"start":3,"end":4,"text":"Cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]},{"target":{"name":"Education_teaching","spans":[{"start":7,"end":8,"text":"Learned"}]},"annotationSets":[{"rank":0,"score":89.18647779416241,"frameElements":[{"name":"Student","spans":[{"start":8,"end":14,"text":"from the Development of PARP Inhibitors"}]}]}]},{"target":{"name":"Cause_to_make_progress","spans":[{"start":10,"end":11,"text":"Development"}]},"annotationSets":[{"rank":0,"score":79.40833332987195,"frameElements":[{"name":"Project","spans":[{"start":11,"end":14,"text":"of PARP Inhibitors"}]}]}]}],"tokens":["Synthetic","Lethality","and","Cancer","Therapy",":","Lessons","Learned","from","the","Development","of","PARP","Inhibitors","."]}
{"frames":[{"target":{"name":"Intentionally_create","spans":[{"start":12,"end":13,"text":"synthesis"}]},"annotationSets":[{"rank":0,"score":49.830695167081835,"frameElements":[{"name":"Created_entity","spans":[{"start":13,"end":22,"text":"of mutations in multiple genes results in cell death"}]}]}]},{"target":{"name":"Quantity","spans":[{"start":16,"end":17,"text":"multiple"}]},"annotationSets":[{"rank":0,"score":24.383194236064003,"frameElements":[{"name":"Quantity","spans":[{"start":16,"end":17,"text":"multiple"}]},{"name":"Individuals","spans":[{"start":18,"end":19,"text":"results"}]}]}]},{"target":{"name":"Causation","spans":[{"start":18,"end":19,"text":"results"}]},"annotationSets":[{"rank":0,"score":77.15995004633055,"frameElements":[{"name":"Cause","spans":[{"start":17,"end":18,"text":"genes"}]},{"name":"Effect","spans":[{"start":19,"end":22,"text":"in cell death"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":20,"end":21,"text":"cell"}]},"annotationSets":[{"rank":0,"score":16.154121168251244,"frameElements":[{"name":"Building_part","spans":[{"start":20,"end":21,"text":"cell"}]}]}]},{"target":{"name":"Death","spans":[{"start":21,"end":22,"text":"death"}]},"annotationSets":[{"rank":0,"score":44.97573007138291,"frameElements":[]}]},{"target":{"name":"Supply","spans":[{"start":23,"end":24,"text":"provides"}]},"annotationSets":[{"rank":0,"score":74.22658142966361,"frameElements":[{"name":"Supplier","spans":[{"start":20,"end":22,"text":"cell death"}]},{"name":"Theme","spans":[{"start":24,"end":33,"text":"a framework to design novel therapeutic approaches to cancer"}]}]}]},{"target":{"name":"Coming_up_with","spans":[{"start":27,"end":28,"text":"design"}]},"annotationSets":[{"rank":0,"score":42.16964303706291,"frameElements":[{"name":"Idea","spans":[{"start":28,"end":31,"text":"novel therapeutic approaches"}]}]}]},{"target":{"name":"Cure","spans":[{"start":29,"end":30,"text":"therapeutic"}]},"annotationSets":[{"rank":0,"score":46.42128084803626,"frameElements":[]}]},{"target":{"name":"Means","spans":[{"start":30,"end":31,"text":"approaches"}]},"annotationSets":[{"rank":0,"score":21.874378761180683,"frameElements":[{"name":"Means","spans":[{"start":30,"end":31,"text":"approaches"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":32,"end":33,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":37.097026595515736,"frameElements":[]}]}],"tokens":["The","genetic","concept","of","synthetic","lethality",",","in","which","the","combination","or","synthesis","of","mutations","in","multiple","genes","results","in","cell","death",",","provides","a","framework","to","design","novel","therapeutic","approaches","to","cancer","."]}
{"frames":[{"target":{"name":"Existence","spans":[{"start":1,"end":3,"text":"there are"}]},"annotationSets":[{"rank":0,"score":47.840448631485685,"frameElements":[{"name":"Entity","spans":[{"start":0,"end":1,"text":"Already"}]}]}]},{"target":{"name":"Time_vector","spans":[{"start":0,"end":1,"text":"Already"}]},"annotationSets":[{"rank":0,"score":11.029443673770585,"frameElements":[{"name":"Direction","spans":[{"start":0,"end":1,"text":"Already"}]}]}]},{"target":{"name":"Omen","spans":[{"start":3,"end":4,"text":"promising"}]},"annotationSets":[{"rank":0,"score":29.72335218523301,"frameElements":[]}]},{"target":{"name":"Sign","spans":[{"start":4,"end":5,"text":"indications"}]},"annotationSets":[{"rank":0,"score":9.118766578846731,"frameElements":[{"name":"Indicator","spans":[{"start":4,"end":5,"text":"indications"}]}]}]},{"target":{"name":"Trial","spans":[{"start":8,"end":9,"text":"trials"}]},"annotationSets":[{"rank":0,"score":48.384072926732706,"frameElements":[]}]},{"target":{"name":"Using","spans":[{"start":13,"end":14,"text":"using"}]},"annotationSets":[{"rank":0,"score":93.31058643964982,"frameElements":[{"name":"Instrument","spans":[{"start":14,"end":23,"text":"poly -LRB- ADP-ribose -RRB- polymerase -LRB- PARP -RRB- inhibitors"}]}]}]},{"target":{"name":"Means","spans":[{"start":35,"end":36,"text":"approach"}]},"annotationSets":[{"rank":0,"score":23.088546521414653,"frameElements":[{"name":"Means","spans":[{"start":35,"end":36,"text":"approach"}]}]}]},{"target":{"name":"Capability","spans":[{"start":36,"end":37,"text":"could"}]},"annotationSets":[{"rank":0,"score":43.51217565325652,"frameElements":[{"name":"Event","spans":[{"start":38,"end":39,"text":"beneficial"}]},{"name":"Entity","spans":[{"start":34,"end":36,"text":"this approach"}]}]}]}],"tokens":["Already","there","are","promising","indications",",","from","clinical","trials","exploiting","this","concept","by","using","poly","-LRB-","ADP-ribose","-RRB-","polymerase","-LRB-","PARP","-RRB-","inhibitors","in","patients","with","germline","BRCA1","or","BRCA2","gene","mutations",",","that","this","approach","could","be","beneficial","."]}
{"frames":[{"target":{"name":"Discussion","spans":[{"start":1,"end":2,"text":"discuss"}]},"annotationSets":[{"rank":0,"score":79.16902791684656,"frameElements":[{"name":"Interlocutor_1","spans":[{"start":0,"end":1,"text":"We"}]},{"name":"Topic","spans":[{"start":2,"end":32,"text":"the biological rationale for BRCA-PARP synthetic lethality , how the synthetic lethal approach is being assessed in the clinic , and how mechanisms of resistance are starting to be dissected"}]}]}]},{"target":{"name":"Weapon","spans":[{"start":3,"end":4,"text":"biological"}]},"annotationSets":[{"rank":0,"score":62.24828663531479,"frameElements":[{"name":"Weapon","spans":[{"start":3,"end":4,"text":"biological"}]}]}]},{"target":{"name":"Killing","spans":[{"start":13,"end":14,"text":"lethal"}]},"annotationSets":[{"rank":0,"score":81.9565062339273,"frameElements":[{"name":"Instrument","spans":[{"start":14,"end":15,"text":"approach"}]}]}]},{"target":{"name":"Means","spans":[{"start":14,"end":15,"text":"approach"}]},"annotationSets":[{"rank":0,"score":20.08029187744842,"frameElements":[{"name":"Means","spans":[{"start":14,"end":15,"text":"approach"}]},{"name":"Descriptor","spans":[{"start":13,"end":14,"text":"lethal"}]}]}]},{"target":{"name":"Assessing","spans":[{"start":17,"end":18,"text":"assessed"}]},"annotationSets":[{"rank":0,"score":93.00630526338685,"frameElements":[{"name":"Phenomenon","spans":[{"start":11,"end":15,"text":"the synthetic lethal approach"}]}]}]},{"target":{"name":"Means","spans":[{"start":24,"end":25,"text":"mechanisms"}]},"annotationSets":[{"rank":0,"score":14.519027081098958,"frameElements":[{"name":"Means","spans":[{"start":24,"end":25,"text":"mechanisms"}]},{"name":"Purpose","spans":[{"start":23,"end":24,"text":"how"}]}]}]},{"target":{"name":"Activity_start","spans":[{"start":28,"end":29,"text":"starting"}]},"annotationSets":[{"rank":0,"score":74.34763824948163,"frameElements":[{"name":"Activity","spans":[{"start":29,"end":32,"text":"to be dissected"}]},{"name":"Agent","spans":[{"start":24,"end":27,"text":"mechanisms of resistance"}]}]}]},{"target":{"name":"Inspecting","spans":[{"start":31,"end":32,"text":"dissected"}]},"annotationSets":[{"rank":0,"score":47.74261818165979,"frameElements":[]}]}],"tokens":["We","discuss","the","biological","rationale","for","BRCA-PARP","synthetic","lethality",",","how","the","synthetic","lethal","approach","is","being","assessed","in","the","clinic",",","and","how","mechanisms","of","resistance","are","starting","to","be","dissected","."]}
{"frames":[{"target":{"name":"Using","spans":[{"start":0,"end":1,"text":"Applying"}]},"annotationSets":[{"rank":0,"score":87.42159494154475,"frameElements":[{"name":"Instrument","spans":[{"start":1,"end":5,"text":"the synthetic lethal concept"}]},{"name":"Purpose","spans":[{"start":5,"end":13,"text":"to target non-BRCA-mutant cancers also has clear potential"}]}]}]},{"target":{"name":"Killing","spans":[{"start":3,"end":4,"text":"lethal"}]},"annotationSets":[{"rank":0,"score":80.36494056185695,"frameElements":[{"name":"Instrument","spans":[{"start":4,"end":5,"text":"concept"}]}]}]},{"target":{"name":"Aiming","spans":[{"start":6,"end":7,"text":"target"}]},"annotationSets":[{"rank":0,"score":35.74624170322392,"frameElements":[]}]},{"target":{"name":"Medical_conditions","spans":[{"start":8,"end":9,"text":"cancers"}]},"annotationSets":[{"rank":0,"score":39.77885705099274,"frameElements":[]}]},{"target":{"name":"Possession","spans":[{"start":10,"end":11,"text":"has"}]},"annotationSets":[{"rank":0,"score":32.732602724391185,"frameElements":[{"name":"Possession","spans":[{"start":11,"end":13,"text":"clear potential"}]},{"name":"Owner","spans":[{"start":7,"end":9,"text":"non-BRCA-mutant cancers"}]}]}]},{"target":{"name":"Obviousness","spans":[{"start":11,"end":12,"text":"clear"}]},"annotationSets":[{"rank":0,"score":43.626557144543966,"frameElements":[{"name":"Phenomenon","spans":[{"start":12,"end":13,"text":"potential"}]}]}]},{"target":{"name":"Capability","spans":[{"start":12,"end":13,"text":"potential"}]},"annotationSets":[{"rank":0,"score":35.678912633905796,"frameElements":[{"name":"Degree","spans":[{"start":11,"end":12,"text":"clear"}]}]}]},{"target":{"name":"Discussion","spans":[{"start":16,"end":17,"text":"discuss"}]},"annotationSets":[{"rank":0,"score":81.66663234043625,"frameElements":[{"name":"Interlocutor_1","spans":[{"start":15,"end":16,"text":"we"}]},{"name":"Topic","spans":[{"start":17,"end":27,"text":"how some of the principles learned in developing PARP inhibitors"}]}]}]},{"target":{"name":"Relational_quantity","spans":[{"start":18,"end":19,"text":"some"}]},"annotationSets":[{"rank":0,"score":15.170383266637113,"frameElements":[]}]},{"target":{"name":"Education_teaching","spans":[{"start":22,"end":23,"text":"learned"}]},"annotationSets":[{"rank":0,"score":96.67789604105718,"frameElements":[]}]},{"target":{"name":"Cause_to_make_progress","spans":[{"start":24,"end":25,"text":"developing"}]},"annotationSets":[{"rank":0,"score":75.1769854758405,"frameElements":[{"name":"Project","spans":[{"start":25,"end":26,"text":"PARP"}]}]}]},{"target":{"name":"Likelihood","spans":[{"start":27,"end":28,"text":"might"}]},"annotationSets":[{"rank":0,"score":25.4635596568072,"frameElements":[{"name":"Hypothetical_event","spans":[{"start":15,"end":27,"text":"we discuss how some of the principles learned in developing PARP inhibitors"}]}]}]},{"target":{"name":"Bringing","spans":[{"start":29,"end":30,"text":"drive"}]},"annotationSets":[{"rank":0,"score":91.21830061376889,"frameElements":[{"name":"Agent","spans":[{"start":15,"end":16,"text":"we"}]},{"name":"Theme","spans":[{"start":30,"end":36,"text":"the development of additional genetic approaches"}]}]}]},{"target":{"name":"Event","spans":[{"start":31,"end":32,"text":"development"}]},"annotationSets":[{"rank":0,"score":36.70206825410379,"frameElements":[{"name":"Event","spans":[{"start":32,"end":36,"text":"of additional genetic approaches"}]}]}]},{"target":{"name":"Increment","spans":[{"start":33,"end":34,"text":"additional"}]},"annotationSets":[{"rank":0,"score":16.251131356217773,"frameElements":[{"name":"Class","spans":[{"start":35,"end":36,"text":"approaches"}]}]}]},{"target":{"name":"Means","spans":[{"start":35,"end":36,"text":"approaches"}]},"annotationSets":[{"rank":0,"score":21.610191578225983,"frameElements":[{"name":"Means","spans":[{"start":35,"end":36,"text":"approaches"}]}]}]}],"tokens":["Applying","the","synthetic","lethal","concept","to","target","non-BRCA-mutant","cancers","also","has","clear","potential",",","and","we","discuss","how","some","of","the","principles","learned","in","developing","PARP","inhibitors","might","also","drive","the","development","of","additional","genetic","approaches","."]}
